Doing the Right Things Right in Bioresearch – The PPH plus Newsletter
In its latest Newsletter, PPH plus provides an interpretation of the 2017 update of the U.S. FDA’s BIMO (Bioresearch Monitoring) metrics as far as GCP inspections at clinical investigator and sponsor/CRO sites are concerned.
The periodical also introduces to the new tracking tool for EMA’s relocation from London to Amsterdam as per EMA’s press release of 5 March 2018.
The bulletin finally encourages the attendance of the 34th Annual DGPharMed Conference on Pharmaceutical Medicine with its main theme of “Medicines and Device Development: Clever and Smart!”. It will take place in Berlin from 22 to 23 March 2018.
For details on the cutting-edge PPH plus clinical development services, please contact the PPH plus team directly.